Deaths from COVID have reached levels not seen since late March 2020,
COVID-19 fatalities It reached new lows this week, reaching levels not seen since late March 2020, when the pandemic just started.
An estimated 1,160 Americans have died from the virus this week, according to the Centers for Disease Control and Prevention.
The next lowest was the week of March 18, 2020, with 169 deaths.
More than 1 million people in the United States have died from COVID-19 since the pandemic began.
ABC News Contributor and Chief Dr. John Braunstein said: Innovation his officer at Boston Children’s Hospital.
The number of cases has also dropped significantly, with fewer than 100,000 people testing positive this week. Experts warn that the number of cases may be significantly underestimated due to the widespread availability of home testing.
A new XBB.1.16 omicron subvariant may be responsible for the recent surge in cases in India.
It now accounts for nearly 10% of new cases in the United States, but it appears to be less serious than similar subvariants, experts say.
“We are still constantly concerned about some new variants and this is why surveillance and public health action are so important, but on an individual level we can rest assured that we are in a perfectly good place. I think,” said Braunstein.
More than 50 million Americans received CDC, the latest COVID bivalent vaccine data indicate.
Uptake rates have slowed since the beginning of the year, with only 5 million people vaccinated in the last few months.
Also, the FDA recently announced a new simplified immunization schedule for COVID vaccines.
People over the age of 65 are eligible to receive a second bivalent injection 4 months after the first. An immunocompromised patient may also receive another booster two months after her first and may be eligible for additional doses at the discretion of the healthcare provider.
“We don’t know what the fall surge will bring, but given the rapid decline in deaths and hospitalizations over time, this could be the future, even if new variants emerge. It is a very positive outlook for
